WPG Advisers’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
WPG Advisers's BMY Position: Q3 2026 in Review
WPG Advisers increased its Bristol-Myers Squibb (BMY) stake by 1.4% in Q3 2026, buying an estimated $2.4K and bringing the position to 2,664 shares worth $166K. The position accounts for 0.09% of the portfolio, ranked #122.
WPG Advisers first reported a position in BMY in Q4 2024 and has held it in 8 quarters since. 1,436 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- WPG Advisers held 2,664 shares of Bristol-Myers Squibb worth $166K as of Q3 2026.
- WPG Advisers bought 38 Bristol-Myers Squibb shares in Q3 2026, an estimated $2.4K.
- Bristol-Myers Squibb made up 0.09% of WPG Advisers's portfolio in Q3 2026, its #122 holding.
- WPG Advisers first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 8 quarters since.
- 1,436 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on WPG Advisers's 13F filing for Q3 2026, filed 27 Oct 2026.